Despite enormous global inequalities in health, only a small proportion of medical research has addressed problems primarily affecting the world's poorest people. To address this, reports by the Ad Hoc Committee on Health Research (1996) 1 and International Conference on Health Research for Development 2 together established a consensus on five core recommendations for the action needed to move towards a more equitable distribution of research resources. These called for action to: correct the 10/90 gap in research funding and set priorities; build up the capacity of health research systems in developing countries; create international research networks and public -private partnerships; increase funding for health research by developing countries; and create health research forums to monitor progress in health research. 3 These recommendations together with the United Nations' Millennium Development Goals led to a number of important developments. The Global Forum for Health Research 10/90 Report on Health Research 2003 -2004 found that the landscape of medical research funding changed significantly between 1990 and 2003 and reported that there were now 'many more actors engaged in funding or conducting health research relevant to the needs of developing countries', estimating that global expenditure on research had 'more than quadrupled'. The report noted that much of this new research took the form of emerging international research networks. Among others, the report identified the following: The Roll Back Malaria Partnership; the Global Alliance for TB Drug Development and HIV/AIDS. Such collaborations bring together diverse, distributed but interdependent groups of 'actors' in formations which may be temporary and partial, or long-term, substantial and interdependent. These include researchers, institutions such as universities and research institutes in both developed and developing countries, funders, research ethics committees, national ethics advisory bodies, health professionals and local community advisory boards. These developments continue 4 and both the scale of the research being carried out on global health, and the shift towards more collaborative, networked approaches to global health research have been further encouraged by initiatives such as the Grand Challenges in Global Health Scheme 5 (http://www.grandchallenges.org/).
Ethical issues in collaborative global health research
The emergence of collaborative global health research initiatives has complex ethical implications arising out of the interplay between globalized research collaborations and the ways in which such research is manifested locally. These are complementary to and interwoven with the well-described ethical issues arising out of global health inequalities, 6,7 but present qualitatively new challenges. Our research seeks to address ethical issues arising in four such challenging areas. Specifically, community engagement, global ethics governance, the ethics of global research collaboration and the respective roles and responsibilities of research actors in large-scale global health collaborations. Each of these four areas is discussed in more detail below.
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Community engagement
'Collaborative partnership' and 'social value' have been proposed as 'benchmarks' against which the ethics of research in developing countries should be assessed. 8, 9 This is driven both by recognition of the need for locally relevant health research, i.e. research with 'social value', and by awareness of the potential for exploitation in contexts of vulnerability and inequality. 7, 10, 11 The achievement of these benchmarks is only possible in the context of effective community engagement and accountability. 12 -14 Despite this growing emphasis on the importance of community engagement, there is relatively little published experience of engagement in practice and there have been a number of recent calls for further research on this important topic. 13, 15, 16 Successful and appropriate community engagement presents a number of challenges. Some of these relate to the question of how the relevant community is to be identified. 13 The question 'who is the community?' also requires an understanding of the relationships between science and collectives such as 'the community' as both dynamic and complex. 17 -19 Other challenges concern the identification and establishment of procedures, principles and mechanisms of engagement that are fair, inclusive, accountable and appropriate. 20, 21 A related issue concerns the relationship between community engagement and community consent, and the extent to which communities should be involved in the setting of research agendas, priorities and methods. This presents particular difficulties in collaborations where even many of the scientific partners will not understand the highly specialized research being carried out by other partners and very few will understand the collaborative enterprise as a whole. Such research also presents challenges for community engagement arising out of the complexity of concepts and practices such as 'datasharing' and because the harms and benefits of such research often relate to populations rather than to individuals. 22 A key practical ethical issue for scientific networks committed to community engagement is how to achieve an appropriate balance between shared good community engagement practice across the network and sensitivity to important local variation.
Global ethics governance
Ensuring that collaborative research meets the needs of people in developing countries requires the development of appropriate models of governance. The governance environment within which such research currently takes place is highly complex. The US Office for Human Research Protections lists more than 1100 international, regional and national examples of guidance and regulation on the ethical conduct of research. 23 Researchers in collaborative studies are sometimes faced with applying multiple and conflicting forms of guidance; or alternatively, may be working in novel scientific fields or contexts with little specialist guidance available. This means that one of the challenges facing collaborative research networks is how to develop rigorous and transparent procedures to inform the development of best practice in conducting their research against the background of guidance which may be complex, conflicting or absent.
It is widely accepted that medical research requires independent, competent and transparent ethical review. 7, 8, 10, 11, 24 In practice, however, the effective and appropriate functioning of research ethics review in developing country settings is frequently undermined not only by the complexity of the guidance but also by inadequate training and resources. 25 -27 In some settings effective local review may be entirely non-existent. 12 
The ethics of research collaboration
Collaborative global health research requires the establishment of large and diverse multinational scientific networks bringing together diverse yet interdependent forms of expertise and institutions in developed and developing countries. This means that a key factor in successful research is the building and maintenance of the relationships, shared values, practices and trust underpinning collaborative science, and the mechanisms for working in the context of different ethical values and commitments. Such consortia will for example need to reach agreement on particular occasions about important ethical principles relating to their relationship with 'their' research participants. This may involve negotiating the appropriate balance between the need for standardization and shared ethical practices across the network and for diversity and appropriateness to local settings.
This suggests that in addition to, but interwoven with recognizable ethical issues such as consent, collaborative research presents a number of 'internal' ethical issues including those arising in the fair sharing of data and samples between partners, the development of scientific capacity across the network, the allocation of scientific resources, decisions about authorship and ownership of intellectual property. Some such issues have both an 'internal' and an 'external' aspect. For example, the need to reach agreement about the development of appropriate mechanisms for the management of the release of data raises questions about the balance between promoting research in the wider scientific community on the one hand and the responsibility for networks to protect the emerging scientific capacity in developing countries, and particularly the capacity of partners within the network. If the data produced by the network on the basis of samples and phenotype descriptions collected by partners in developing countries are exploited by institutions in the North at the expense of emergent capacity in the South, this has the potential to undermine long-term collaboration. 28 
Roles and responsibilities of research actors
Responsibility for addressing global health inequalities and key development goals is inevitably shared. 3, 21 It has been argued that researchers have an obligation to promote equity in health in developing countries. 21, 29 But how should such responsibilities be understood in the context of collaborative global health research? These are important questions about the moral responsibilities arising during research in developing countries and raise important questions about how such responsibilities and roles are to be identified and negotiated in the context of collaborative global health research and what forms of accountability might be appropriate.
The fact that collaborative global health research involves multiple collaborative relationships and communities suggests the importance of negotiating and reaching clarity about roles and responsibilities before research begins, 10,11 and as it proceeds. There may be particular advantages in this regard to the development of long-term community engagement. This suggests the possibility, and perhaps desirability (given concerns about 'one-size-fits-all' approaches), of the emergence of different solutions in different sites. Where this is the case, who will be responsible for achieving good practice across the network? What will this mean and how will it be achieved?
A key cluster of issues relating to the roles and responsibilities of research actors, and their negotiation, will inevitably be those related to questions of benefitsharing, social value, intellectual property, appropriate standards of care and the identification of post-research responsibilities. 12, 14 Similar issues arise in relation to capacity-building. Questions arise about to what extent is capacity-building a responsibility of research networks and their funders and what forms might it be appropriate for such capacity-building to take. 6 
Conclusions
The growth of collaborative global health networks presents a number of ethical issues not previously encountered in combination. It also presents a number of new theoretical challenges. It is our view that an ethics capable of making sense of these emerging and interdependent phenomena will itself need to be collaborative and multisited if it is to be capable of grasping the implications of both global collaboration and the manifestation of the global in the local, where the 'local' is to be found both in developed and developing country sites. It is also our view that such research will necessarily have a strong empirical component.
